Project Title	Funding Source	Amount (£)	Period	PI
GBA mutations and Parkinson disease: Molecular mechanisms and Therapeutic intervention	Parkinson's UK	319,324	2017-2020	Tony Schapira
TIG-B project plan no. 4	Eisai Ltd	756,955	2014-2018	Tony Schapira
Glucocerebrosidase mutations in Parkinson disease: molecular pathogenesis, and the basis for personalised therapy with small molecule chaperones	MRC	934,952	2015-2019	Tony Schapira
Glucocerebrosidase chaperones in Parkinson disease	Parkinson's UK	307,081	2015-2018	Tony Schapira
SYSMEDPD - systems medicine of mitochondrial Parkinson's disease	EC Horizon 2020	389,986	2015-2019	Tony Schapira
GBA1 mutations in Parkinson disease; Clinical and biochemical prodrome risk profile pathogenetic modelling for therapeutic intervention	JPND /MRC	297,289	2016-2019	Tony Schapira
Ambroxol in the modification of PD progression (AIM-PD)	Cure Parkinson's Trust	321,750	2016-2018	Tony Schapira
	Royal Embassy of Saudi Arabia Cultural Bureau	198,507	2015-2019	Tony Schapira
GBA MUTATIONS AND PARKINSON DISEASE: MOLECULAR MECHANISMS AND THERAPEUTIC INTERVENTION	Parkinson's UK	319,325	2018-2021	Tony Schapira
Understanding and predicting parkinson's progression	Parkinson's UK	99,169	2017-2020	Huw Morris
A longitudinal clinical and biomarker study of Progressive Supranuclear Palsy and Cortico-Basal Syndrome (PSP Research Network)	PSP Association	294,808	2014-2018	Huw Morris
Development of CSF biobank and CSF biomarkers for PSP	PSP Association	184,697	2015-2019	Huw Morris
Sara Koe Research Fellowship (sponsor)	PSP Association	228,208	2015-2019	Huw Morris
European registry and longitudinal study of Cortico-Basal Syndrome	CBD Solutions	561,536	2014-2019	Huw Morris
A longitudinal biomarker study of sports related head injury and outcomes	Drake Foundation	500,000	2015-2019	Huw Morris
A participant's guide to userfriendly information in genetic research - institutional strategic support fund	Welcome Trust	1,498	2015-2018	Huw Morris
Create a nested CPT resource with the CANDAS biobank using the CANDAS consent to store genetic data from PD-STAT	Cure Parkinson's Trust	45,000	2016-2019	Huw Morris
Movement Disorders Centre Coordinator	NIHR Biomedical Research Centre	47,789	2016-2018	Huw Morris
European Multicentre Tics and Streptococcal Infections Study (EMTICS)	EU Commission FP7	111,302	2011-2018	Anette Schrag
How commonly is late onset depression a manifestation of prodromal Parkinson’s disease/Lewy body disease?	GE Healthcare UK Ltd	105,000	2013-2018	Anette Schrag
Royal Free Parkinson'sPPI Research Group, institutional strategic support fund	Welcome Trust	550	2015-2018	Anette Schrag
Care of Late Stage Parkinsonism	JPND	252,403	2014-2019	Anette Schrag
Developmnent of IMPDS , of a new comhrehensive,parkinson's NON Motor Symptoms scale	Inter. Parkinson's and Movement Disorders Society	77,376	2015-2018	Anette Schrag
PREDICT-PD Parkinson’s UK	Parkinson's UK	594,111	2017-2021	Anette Schrag
Antidepressants for depression in people with Parkinson's disease	NIHR	946,851	2018-2022	Anette Schrag
Detailed investigation of SNCA CNV mosaicism in Parkinson's disease	MJF Foundation	112,175	2018-2019	Christos Proukakis
Mitochondrial Biogenesis and disease	MRC Senior Non-Clinical Fellowship	1,042,186	2016-2019	Antonella Spinazzola
An integrated biochemical, genetic and transcriptomic approach to defining target therapeutic pathways in Parkinson’s disease	MRC	221,467	2018-2021	Philip Campbell
	TOTAL	9,049,828